x
0

Biotron Ltd (BIT)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery

Website notifications

Mobile App notifications

Add to/Remove from a Portfolio My Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.035 +0.001    +2.94%
24/03 - Closed. Currency in AUD ( Disclaimer )
Type: Equity
Market: Australia
ISIN: AU000000BIT4 
  • Volume: 11,696
  • Bid/Ask: 0.034 / 0.035
  • Day's Range: 0.035 - 0.035
Start Trading
Biotron Ltd 0.035 +0.001 +2.94%

BIT Overview

 
Information about the Biotron Ltd Stock. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close0.034
Day's Range0.035 - 0.035
Revenue1.55M
Open0.035
52 wk Range0.032 - 0.083
EPS - 0.01
Volume11,696
Market Cap10.98M
Dividend (Yield)0 (N/A)
Average Volume (3m)476,666
P/E RatioN/A
Beta1.05
1-Year Change - 51.39%
Shares Outstanding313,765,329
Next Earnings DateN/A

Technical Summary

Type 5 mins 15 mins Hourly Daily Monthly
Moving Averages Neutral Sell Sell Strong Sell Strong Sell
Technical Indicators Neutral Neutral Sell Strong Sell Strong Sell
Summary Neutral Neutral Sell Strong Sell Strong Sell

Candlestick Patterns

Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Bullish Engulfing 1H Current
Thrusting Bearish 5H Current
Bullish Hammer 1D Current
Completed Patterns
Homing Pigeon 1D 2 Mar 22, 2017
Dragonfly Doji 1H 2 Mar 23, 2017 14:00
Homing Pigeon 5H 3 Mar 22, 2017 08:00

Biotron Ltd News & Analysis

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery

Website notifications

Mobile App notifications

  Name Last High Low Chg. Chg. % Vol. Time
  MMJ Phytotech 0.660 0.670 0.615 +0.045 +7.32% 7.63M 24/03  
  Auscann Group 0.760 0.775 0.730 +0.040 +5.56% 3.08M 24/03  
  MGC Pharma 0.076 0.076 0.068 +0.007 +10.14% 39.56M 24/03  
  Telstra Corporation. 4.590 4.600 4.530 +0.070 +1.55% 20.88M 24/03  
  A2 Milk Company Ltd 2.610 2.640 2.600 +0.010 +0.38% 2.23M 24/03  
  Creso Pharma 0.825 0.930 0.810 0.000 0.00% 0 22/03  
  Commonwealth Bank Australia 83.380 83.890 82.680 +0.430 +0.52% 2.08M 24/03  
  Stemcell United Ltd 0.190 0.225 0.185 -0.035 -15.56% 3.39M 24/03  
  Zelda Therapeutics 0.083 0.086 0.082 +0.001 +1.22% 7.56M 24/03  
  ANZ Banking Group 31.360 31.410 30.695 +0.590 +1.92% 5.14M 24/03  

Biotron Ltd Company Profile

IndustryBiotechnology & Drugs
SectorHealthcare
Employees

4

Equity Type

ORD

Biotron Limited is an Australia-based biotechnology company. The Company is engaged in the funding and management of intermediate, and applied biotechnology research and development projects. The Company is focused on the ongoing clinical development of its antiviral platform. The Company's lead antiviral drug, BIT225 is in mid-stage clinical development with approximately eight clinical trials completed. The Company has conducted clinical trails in human immunodeficiency virus-1 (HIV-1), hepatitis C virus (HCV) and HIV-1/HCV co-infected population. The clinical trials showed that BIT225 targets and reduces levels of HIV-1 residing in long-lived monocyte/macrophage reservoirs. BIT225 has clinical antiviral activity against both HIV-1 and HCV. BIT225 is pan-genotypic and is active against all HCV genotypes, including GT3. The Company designs and develops drugs that target a class of virus protein known as viroporins. Its earlier stage programs include Dengue, Influenza and others.

Read More

Start Trading With Top Industry Brokers

Brokers Regulation Minimum Deposit
National Futures Association (United States), U.S. Commodity Futures Trading Commission (United States), The Financial Conduct Authority (United Kingdom), Australian Securities and Investments Commission (Australia), Financial Industry Regulatory Authority (United States), Investment Industry Regulatory Organization of Canada (Canada), Securities and Exchange Commission (United States), The Securities and Futures Commission (Hong Kong) $250 Start Trading

My Sentiments

Add your sentiment:
or
 
Members' Sentiments:
Bullish
50%
Bearish
50%

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

 
Are you sure you want to delete this chart?
 
 
Replace the attached chart with a new chart ?
Post 1000
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
 
Replace the attached chart with a new chart ?
Post 1000
Please wait a minute before you try to comment again.
 
 
 
Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Add Chart to Comment
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.